These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 229736)
1. Physiological basis for absorptive and renal hypercalciurias. Pak CY Am J Physiol; 1979 Dec; 237(6):F415-23. PubMed ID: 229736 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones. Ritz E; Schmidt-Gayk H; Möhring K Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957 [TBL] [Abstract][Full Text] [Related]
3. Selective effects of thiazide on intestinal absorption of calcium and adsorptive and renal hypercalciurias. Barilla DE; Tolentino R; Kaplan RA; Pak CY Metabolism; 1978 Feb; 27(2):125-31. PubMed ID: 202838 [TBL] [Abstract][Full Text] [Related]
4. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. Pak CY; Oata M; Lawrence EC; Snyder W J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891 [TBL] [Abstract][Full Text] [Related]
5. The role of vitamin D in idiopathic hypercalciuria. Maggio AJ; Coburn JW; Brosman SA; Das S J Urol; 1979 Aug; 122(2):147-51. PubMed ID: 222916 [No Abstract] [Full Text] [Related]
6. Pathophysiology of hypercalciuria. Coe FL; Bushinsky DA Am J Physiol; 1984 Jul; 247(1 Pt 2):F1-13. PubMed ID: 6377922 [TBL] [Abstract][Full Text] [Related]
7. Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Zerwekh JE; Pak CY Metabolism; 1980 Jan; 29(1):13-7. PubMed ID: 7351872 [TBL] [Abstract][Full Text] [Related]
8. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763 [TBL] [Abstract][Full Text] [Related]
9. Oral calcium tolerance test and serum calcitonin in calcium stone formers. Kohri K; Kataoka K; Iguchi M; Yachiku S; Kurita T Urol Res; 1983; 11(1):33-7. PubMed ID: 6304968 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic hypercalciuria. Pak CY Adv Exp Med Biol; 1977; 81():309-17. PubMed ID: 197820 [No Abstract] [Full Text] [Related]
12. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. Broadus AE; Dominguez M; Bartter FC J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682 [TBL] [Abstract][Full Text] [Related]
13. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides. Hering F; Lutzeyer W Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408 [TBL] [Abstract][Full Text] [Related]
18. The tale of parathyroid function in idiopathic hypercalciuria. Hess B; Jaeger P Scanning Microsc; 1993 Mar; 7(1):403-8. PubMed ID: 8316809 [TBL] [Abstract][Full Text] [Related]
19. The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers. Peacock M Contrib Nephrol; 1982; 33():152-62. PubMed ID: 6288323 [No Abstract] [Full Text] [Related]
20. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria. Olmer M; Berland Y; Argemi B Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]